Candel Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Conferences Trial results

24 May 2024

ASCO 2024 abstract movers – Merus convinces, at first

Thursday's unveiling of regular ASCO abstract yielded a few initial winners and losers.

Subscribe to Candel Therapeutics